Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-24 @ 9:59 PM
NCT ID:
NCT02187432
Eligibility Criteria:
Inclusion Criteria:
* Participants ≥ 18 years;
* Clinical diagnosis of ADPKD based on kidney imaging and family history;
* Estimated Glomerular Filtration Rate (eGFR) ≥ 30 ml/min/1.73m2 (Chronic Kidney Disease Epidemiology Collaboration(CKD-EPI)- formula);
* Provided written informed consent.
Exclusion Criteria:
* Receiving chronic renal replacement therapy before enrollment (dialysis, allograft) or anticipated in the following 12 months after enrollment;
* Participation in a clinical trial aiming to modify disease outcome one year or less before enrollment in the EuroCYST study;
* New York Heart Association (NYHA) stadium IV.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02187432
Study Brief:
Protocol Section:
NCT02187432